MORRISVILLE, N.C., Jan. 11, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced that its recently launched corporate website, www.ncontactinc.com, has won a 2011 Interactive Media Award for Best in Class Medical Site, presented by the nonprofit Interactive Media Council. The new website, designed by Studio 1440, has been recognized for excellence in design, development and implementation, through a competition of over 500 international and domestic websites.
John P. Funkhouser, President and CEO of nContact, said, "We designed our new website to represent the direction and vision of our company as we pioneer new treatment alternatives for common cardiac arrhythmias. As we continue to advance our technology and expand treatments to new patient populations, we will look to our website to chronicle our evolution. We appreciate that our efforts have been acknowledged through this prestigious interactive forum and that the concept, design and content has earned such recognition."
nContact's newly enhanced corporate website, with portals for both U.S. and International visitors, provides an in-depth view of the company's Numeris® and EPi-Sense® Guided Coagulation Systems with VisiTrax®, expanded physician resources, detailed images and animation videos.
The "Best in Class" award recognizes the website meets and surpasses standards of excellence in design, usability, innovation in technical features, standards compliance and content, receiving a near perfect score in each category. It is the most prestigious award presented by the Interactive Media Council each year.
About nContact, Inc.nContact is a medical device company founded in 2005 with a mission to develop devices for the endoscopic treatment of arrhythmias, including atrial fibrillation (AF). The Numeris® Coagulation System with VisiTrax® is based on the unique integration of suction, perfusion, and RF energy to ensure the creation of visible, non-conductive, continuous, bi-atrial lesions on the epicardium of a beating heart.
To date, the Numeris® Coagulation System with VisiTrax® is indicated for endoscopic coagulation of cardiac tissue in the United States. nContact has initiated IDE clinical studies for the treatment of AF in both open and closed chest procedures. The Numeris® and EPi-Sense® Coagulation Systems with VisiTrax® have CE Mark approval in Europe for the coagulation of cardiac tissue for the treatment of atrial fibrillation and atrial flutter.
About the Interactive Media Awards
The Interactive Media Awards recognize the highest standards of excellence in website design and development and honor individuals and organizations for their outstanding achievement. Sponsored by the Interactive Media Council, Inc., a nonprofit organization of leading web designers, developers, programmers, advertisers and other web-related professionals, the competition seeks to elevate the standards of excellence on the Internet. For more information visit http://www.interactivemediaawards.com.Media Contacts
T (919) 655-1566
The Ruth Group
T (646) 536-7011
|SOURCE nContact, Inc.|
Copyright©2010 PR Newswire.
All rights reserved